IRIS Accounts Production v24.1.4.33 00587959 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh005879592022-12-31005879592023-12-31005879592023-01-012023-12-31005879592021-12-31005879592022-01-012022-12-31005879592022-12-3100587959ns15:EnglandWales2023-01-012023-12-3100587959ns14:PoundSterling2023-01-012023-12-3100587959ns10:Director12023-01-012023-12-3100587959ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3100587959ns10:SmallEntities2023-01-012023-12-3100587959ns10:AuditExemptWithAccountantsReport2023-01-012023-12-3100587959ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3100587959ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3100587959ns10:FullAccounts2023-01-012023-12-310058795912023-01-012023-12-3100587959ns10:Director22023-01-012023-12-3100587959ns10:Director32023-01-012023-12-3100587959ns10:CompanySecretary12023-01-012023-12-3100587959ns10:RegisteredOffice2023-01-012023-12-3100587959ns5:CurrentFinancialInstruments2023-12-3100587959ns5:CurrentFinancialInstruments2022-12-3100587959ns5:ShareCapital2023-12-3100587959ns5:ShareCapital2022-12-3100587959ns5:RetainedEarningsAccumulatedLosses2023-12-3100587959ns5:RetainedEarningsAccumulatedLosses2022-12-3100587959ns5:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3100587959ns5:PatentsTrademarksLicencesConcessionsSimilar2023-01-012023-12-3100587959ns5:IntangibleAssetsOtherThanGoodwill2022-12-3100587959ns5:IntangibleAssetsOtherThanGoodwill2023-12-3100587959ns5:IntangibleAssetsOtherThanGoodwill2022-12-3100587959ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3100587959ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-31
REGISTERED NUMBER: 00587959 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st December 2023

for

Neo Laboratories Limited

Neo Laboratories Limited (Registered number: 00587959)






Contents of the Financial Statements
for the Year Ended 31st December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Chartered Accountants' Report 5

Neo Laboratories Limited

Company Information
for the Year Ended 31st December 2023







DIRECTORS: S R G Tate
Mrs M J Tate
R E Warriner





SECRETARY: Mrs M J Tate





REGISTERED OFFICE: 29a Crown Street
Brentwood
Essex
CM14 4BA





REGISTERED NUMBER: 00587959 (England and Wales)





ACCOUNTANTS: Moulton Johnson Limited
Chartered Accountants
29a Crown Street
Brentwood
Essex
CM14 4BA

Neo Laboratories Limited (Registered number: 00587959)

Balance Sheet
31st December 2023

31.12.23 31.12.22
Notes £ £ £ £
FIXED ASSETS
Intangible assets 4 504 576

CURRENT ASSETS
Debtors 5 145,316 129,676
Cash at bank - 2
145,316 129,678
CREDITORS
Amounts falling due within one year 6 3,859 840
NET CURRENT ASSETS 141,457 128,838
TOTAL ASSETS LESS CURRENT
LIABILITIES

141,961

129,414

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings 140,961 128,414
SHAREHOLDERS' FUNDS 141,961 129,414

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23rd September 2024 and were signed on its behalf by:





S R G Tate - Director


Neo Laboratories Limited (Registered number: 00587959)

Notes to the Financial Statements
for the Year Ended 31st December 2023

1. STATUTORY INFORMATION

Neo Laboratories Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Trademarks are being amortised evenly over their estimated useful life of ten years.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2022 - 3 ) .

Neo Laboratories Limited (Registered number: 00587959)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2023

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£
COST
At 1st January 2023 1,147
Disposals (424 )
At 31st December 2023 723
AMORTISATION
At 1st January 2023 571
Charge for year 72
Eliminated on disposal (424 )
At 31st December 2023 219
NET BOOK VALUE
At 31st December 2023 504
At 31st December 2022 576

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£ £
Other debtors 145,316 129,676

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£ £
Taxation and social security 3,859 840

7. RELATED PARTY DISCLOSURES

During the year, the company purchased goods from Wallace Manufacturing Chemists Limited, a company under common control, amounting to £156,845 (2022: £52,120).

At the year end, the amount due from Wallace Manufacturing Chemists Limited to the company amounted to £144,983 (2022: £129,374).

Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Neo Laboratories Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Neo Laboratories Limited for the year ended 31st December 2023 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Neo Laboratories Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Neo Laboratories Limited and state those matters that we have agreed to state to the Board of Directors of Neo Laboratories Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Neo Laboratories Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Neo Laboratories Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Neo Laboratories Limited. You consider that Neo Laboratories Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Neo Laboratories Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Moulton Johnson Limited
Chartered Accountants
29a Crown Street
Brentwood
Essex
CM14 4BA


23rd September 2024